Another story of mice and men: The types of RTH

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 23, 2009, Pages 9129-9130

  Webb, Paul ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; PROTIRELIN; THYROID HORMONE; THYROID HORMONE RECEPTOR BETA; THYROTROPIN;

DISEASE CLASSIFICATION; DISEASE MODEL; GOITER; HUMAN; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; NONHUMAN; NOTE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION; SYMPTOMATOLOGY; THYROID HORMONE BLOOD LEVEL; THYROID HORMONE RELEASE; THYROID HORMONE RESISTANCE; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE; TRANSCRIPTION REGULATION;

ANIMALS; HUMANS; MICE; THYROID HORMONE RECEPTORS BETA; THYROID HORMONE RESISTANCE SYNDROME; THYROTROPIN; TRIIODOTHYRONINE;

MUS;

EID: 67249102566     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0904504106     Document Type: Note

References (18)

1. Refetoff S, Weiss RE, Usala SJ (1993) The syndromes of resistance to thyroid hormone. Endocr Rev 14:348-399. (Pubitemid 23168055)
2. Yen PM (2003) Molecular basis of resistance to thyroid hormone. Trends Endocrinol Metab 14:327-333. (Pubitemid 37093130)
3. Chatterjee VK (2001) Resistance to thyroid hormone and peroxisome-proliferator-activated receptor γ resistance. Biochem Soc Trans 29:227-231. (Pubitemid 32587510)
4. Yen PM (2001) Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097-1142. (Pubitemid 32606667)
5. McDermott MT, Ridgway EC (1998) Central hyperthyroidism. Endocrinol Metabol Clinics North America 27:187-203. (Pubitemid 28144962)
6. Weiss RE, Refetoff S (2000) Resistance to thyroid hormone. Rev Endocrine Metabolic Disorders 1:97-108.
7. Beck-Peccoz P, Chatterjee VK (1994) The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 4:225-232. (Pubitemid 24202361)
8. Brucker-Davis F, et al. (1995) Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health Prospective Study. Ann Int Med 123:572-583.
9. Collingwood TN, Adams M, Tone Y, Chatterjee VK (1994) Spectrum of transcriptional, dimerization, and dominant negative properties of 20 different mutant thyroid hormone β-receptors in thyroid hormone resistance syndrome. Mol Endocrinol 8:1262-1277. (Pubitemid 24292603)
10. Machado DS, et al. (2009) A thyroid hormone receptor mutation that dissociates thyroid hormone regulation of gene expression in vivo. Proc Natl Acad Sci USA 106:9441-9446.
11. Gershengorn MC, Weintraub BD (1975) Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH." J Clin Invest 56:633-642.
12. Hayashi Y, Xie J, Weiss RE, Pohlenz J, Refetoff S (1998) Selective pituitary resistance to thyroid hormone produced by expression of a mutant thyroid hormone receptor β gene in the pituitary gland of transgenic mice. Biochem Biophys Res Comm 245:204-210. (Pubitemid 28414271)
13. Abel ED, et al. (1999) Novel insight from transgenic mice into thyroid hormone resistance and the regulation of thyrotropin. J Clin Invest 103:271-279. (Pubitemid 29053145)
14. Cheng SY (2005) Isoform-dependent actions of thyroid hormone nuclear receptors: Lessons from knockin mutant mice. Steroids 70:450-454. (Pubitemid 40626764)
15. Baxter JD, Webb P (2009) Thyroid hormone mimetics: Potential applications in atherosclerosis, obesity, and type 2 diabetes. Nat Rev 8:308-320.
16. Wu SY, et al. (2006) A novel thyroid hormone receptor-β mutation that fails to bind nuclear receptor corepressor in a patient as an apparent cause of severe, predominantly pituitary resistance to thyroid hormone. J Clin Endocrinol Metabol 91:1887-1895.
17. Astapova I, et al. (2008) The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo. Proc Natl Acad Sci USA 105:19544-19549.
18. Togashi M, Nguyen P, Fletterick R, Baxter JD, Webb P (2005) Rearrangements in thyroid hormone receptor charge clusters that stabilize bound 3,5′,5-triiodo-L-thyronine and inhibit homodimer formation. J Biol Chem 280:25665-25673. (Pubitemid 40962276)